Loading...

Phase I/II Trial of Clofarabine and Cytarabine in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia (AAML0523): A Report From the Children’s Oncology Group

BACKGROUND: The discovery of effective re-induction regimens for children with more than one relapse of acute lymphoblastic leukemia (ALL) remains elusive. The novel nucleoside analog clofarabine exhibits modest single agent efficacy in relapsed ALL, though optimal combinations of this agent with ot...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Pediatr Blood Cancer
Main Authors: Cooper, Todd M., Razzouk, Bassem I., Gerbing, Robert, Alonzo, Todd A., Adlard, Kathleen, Raetz, Elizabeth, Gamis, Alan S., Perentesis, John, Whitlock, James A.
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605828/
https://ncbi.nlm.nih.gov/pubmed/23335239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24398
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!